158 related articles for article (PubMed ID: 38191137)
21. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
[TBL] [Abstract][Full Text] [Related]
22. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer.
Wang S; Bruzzi J; Rodriguez-Garza VP; Komaki RR
Clin Lung Cancer; 2006 Jan; 7(4):282-4. PubMed ID: 16512985
[TBL] [Abstract][Full Text] [Related]
23. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
[TBL] [Abstract][Full Text] [Related]
24. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
25. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
26. [Lambert-Eaton myasthenic syndrome].
Motomura M; Fukuda T
Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
[TBL] [Abstract][Full Text] [Related]
27. Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
Titulaer MJ; Maddison P; Sont JK; Wirtz PW; Hilton-Jones D; Klooster R; Willcox N; Potman M; Sillevis Smitt PA; Kuks JB; Roep BO; Vincent A; van der Maarel SM; van Dijk JG; Lang B; Verschuuren JJ
J Clin Oncol; 2011 Mar; 29(7):902-8. PubMed ID: 21245427
[TBL] [Abstract][Full Text] [Related]
28. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
29. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
30. Amifampridine to treat Lambert-Eaton myasthenic syndrome.
Oh SJ
Drugs Today (Barc); 2020 Oct; 56(10):623-641. PubMed ID: 33185628
[TBL] [Abstract][Full Text] [Related]
31. Lambert-Eaton Myasthenic Syndrome.
Kesner VG; Oh SJ; Dimachkie MM; Barohn RJ
Neurol Clin; 2018 May; 36(2):379-394. PubMed ID: 29655456
[TBL] [Abstract][Full Text] [Related]
32. Two Lambert-Eaton Myasthenic Syndrome Patients with Ameliorated Activities of Daily Living Due to Cholinesterase Inhibitors.
Yamasaki H; Futamura N; Funakawa I; Kohara N; Yoshimura S; Motomura M
Intern Med; 2022 Apr; 61(7):1063-1065. PubMed ID: 34544947
[TBL] [Abstract][Full Text] [Related]
33. Lambert-Eaton myasthenic syndrome.
Mareska M; Gutmann L
Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511
[TBL] [Abstract][Full Text] [Related]
34. Lambert-Eaton myasthenic syndrome.
Lipka AF; Verschuuren JJGM
Handb Clin Neurol; 2024; 200():307-325. PubMed ID: 38494285
[TBL] [Abstract][Full Text] [Related]
35. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Payne M; Bradbury P; Lang B; Vincent A; Han C; Newsom-Davis J; Talbot D
J Thorac Oncol; 2010 Jan; 5(1):34-8. PubMed ID: 19934775
[TBL] [Abstract][Full Text] [Related]
36. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
37. Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management.
Evoli A; Liguori R; Romani A; Mantegazza R; Di Muzio A; Giometto B; Pegoraro E; Rodolico C; Vigliani MC;
Neurol Sci; 2014 Apr; 35(4):515-20. PubMed ID: 24481713
[TBL] [Abstract][Full Text] [Related]
38. Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure.
Jiang JR; Shih JY; Wang HC; Wu RM; Yu CJ; Yang PC
J Formos Med Assoc; 2002 Dec; 101(12):871-4. PubMed ID: 12632823
[TBL] [Abstract][Full Text] [Related]
39. Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.
Kunii E; Owaki S; Yamada K; Yoshihara M; Yamaba Y; Takakuwa O; Toyoda T; Akita K
Intern Med; 2022 Jun; 61(11):1739-1742. PubMed ID: 34707051
[TBL] [Abstract][Full Text] [Related]
40. [Seronegative nonparaneoplastic Lambert-Eaton myasthenic syndrome].
Sanadze AG; Sidnev DV; Tumurov DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):77-80. PubMed ID: 28638036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
